In agreement with our observations, WNT5a has been shown to increase Vimentin and CD44 to enhance motility of melanoma cells and nasopharyngeal carcinoma via the Ca2+ signaling pathway40,57. The gene discussed is CD44; the disease is nasopharyngeal carcinoma.